* How were you made aware of this opportunity?AU Employment websiteEmployment websites (Indeed, HigherEd Jobs, etc.)Veterans Assistance ServicesDisability Assistance ServicesNewspaperProfessional JournalListservHR emailSocial MediaState Employment ServiceWalk-inOther Position DetailsRequisition NumberS267PHome Org NameClinical SciencesDivision NameCollege of Veterinary MedicinePosition TitleAssistant/Tech Vet Inpatient (I/II/III) IMC/ICU – Swing ShiftJob Class CodeIC11 (A-C), IC12 (A-C)Appointment StatusFull-timePart-time FTELimited TermNoLimited Term LengthJob SummaryThis is a rotating monthly swing shift:Mon-Thurs 2:00 pm – 12:00 am, Fri – Sun 12:00 pm – 1 amThis position will be working directly with the Emergency/CriticalCare ( ECC ) clinicians and rotating intern doctors to helpfacilitate quality client care and patient flow through the IMC,ICU, and ER.Essential FunctionsResponsibilities include, but are not limited to: oversight andtraining of professional veterinary students regarding care ofanimals, collection of specimens, and handling of animals;transportation and monitoring of patients requiring diagnosticimaging and assistance with obtaining images as needed; assistingclinicians with student examination, treatment, procedures,restraint, and sample collection; anesthetic monitoring for patientrequiring minor procedures in IMC or ICU ; assisting in emergencytriage and stabilization of patients through the ER; assistclinicians with set-up of critical patients as needed, includingventilator and CRRT patients; communicating with referringveterinarians as directed by ECC clinician; operation andmonitoring of patients receiving hyperbaric oxygen therapy;facilitating/coordinating consults with other specialty services;assisting with estimates, inputting charges, and/or similar tasks;other responsibilities as directed by clinicians. *This positionwill not be responsible for primary nursing care of ECC patientsadmitted to IMC or ICU .Education LevelHigh school diploma or equivalent for entry levelField of StudyYears of ExperienceNo experience required for entry levelArea of ExperienceRequirements for Additional Job LevelsDepending on the combination of education and experience, selectedcandidates may be hired as a Veterinary Assistant or Technician,and assigned Levels I, II, or III . Salary range determined byeligibility for Level I, II, or III .Consideration for entry-level Veterinary Assistant requires:A high school diploma or equivalentConsideration for entry-level Veterinary Technician requires:1. Associate’s degree or higher in a technical or scientific fieldrelated to the area of assignment.2. Active license with the Alabama State Board of VeterinaryMedicine as a Veterinary Technician, have met all requirements tobecome licensed, or have passed the Veterinary Technician NationalExam ( VTNE ). Veterinary Technician certification or license mustbe obtained within 6 months of employment. Salary range determinedby eligibility for Level I, II or III .Education LevelField of StudyYears of ExperienceOne (1) year of completed relevant education per year of requiredexperience.Area of ExperienceRequirements for Additional Job LevelsMinimum Skills and AbilitiesMinimum Technology SkillsMinimum License and CertificationsTo qualify for Tech: Veterinary Technician Certification havingpassed the Veterinary Technician National Exam ( VTNE ).Desired QualificationsSalary Grade27Salary Range$20,300 – $52,100Job CategoryAgricultural/Veterinary MedicineWorking Hours if Non-TraditionalRotating monthly swing shift: Mon -Thurs 2:00 pm – 2:00 am, Fri -Sun 12:00 pm – 1 amList any hazardous conditions or physical demands required bythis positionPosting Date06/16/2020Closing DateEEO StatementAUBURN UNIVERSITY IS AN AFFIRMATIVE ACTION / EQUAL OPPORTUNITYEMPLOYER . It is our policy to provide equal employmentopportunities for all individuals without regard to race, sex,religion, color, national origin, age, disability, protectedveteran status, genetic information, sexual orientation, genderidentity, or any other classification protected by applicablelaw.Special Instructions to ApplicantsQuick Link for Internal Postingshttps://www.auemployment.com/postings/7422Documents Needed to ApplyRequired DocumentsResumeCover LetterOptional DocumentsTranscriptsLetter of RecommendationOtherSupplemental QuestionsRequired fields are indicated with an asterisk (*). * Please select the answer that best describes your currentemployment relationship with Auburn University.Not a current Auburn employeeCurrent Auburn employee in position less than one yearCurrent Auburn employee in position more than one year * Do you have a high school diploma or equivalent?YesNo
The baking industry has been criticised for trying to make bread cheap. On these pages, organic campaigner Andrew Whitley dismissed as “myth” that low price is compatible with quality. Elsewhere, Craig Sams, founder of Green & Blacks organic chocolate, has said that “the price we pay [for cheap bread] is irritable bowel syndrome, coeliac’s disease and wheat and gluten allergies”. Such views are the result of prejudice against the application of engineering and science to food production.Low price and high quality are not mutually exclusive. If you do not aspire to cheap mass production of quality foods, you will inevitably end up denying people access to the foods they want and need.I work as an academic chemical engineer, and much of my time is spent thinking about food processing, including bread baking. One of the historic roles of engineers has been to deliver things more cheaply, while maintaining – if not improving – quality. For example, mechanical engineers have helped to make transport faster and cheaper, allowing me to eat fresher and more varied vegetables than I could a decade ago. We should aim to continue doing the same in baking.The effects of inflation and changing incomes make it difficult to actually put a price on how much cheaper bread is today than in the past. US authors Michael Cox and Richard Alm overcame this in their 1999 study of relative affluence, Myths of rich and poor, using the basis that “the real price of whatever we buy is how long we have to work to earn the money for it”. As such, they calculated that the average American work time required to buy a 1lb (450g) loaf of bread has decreased from 16 minutes in 1910 to 3.5 minutes in 1999.In principle, this means that we can all work that little bit less than our parents did and enjoy consuming just as much. Measuring efficiency in this way, as output per man per day, is a useful progress chart. Comparative cheapness has helped make food scarcity rare in most developed countries. Indeed, health problems are often associated with over-consumption of food, particularly refined foods.There has never been a golden age of food production. Before industrialisation, agriculture in Britain was at the mercy of nature, resulting in periodic famine. In Victorian cities, adulteration of flour with alum, to bolster loaf weight and make expensive flour go further, contributed to widespread malnutrition. Our current ability to produce bread cheaply, while meeting strict regulatory standards, should be celebrated.We can appreciate the qualities of labour-intensive ’artisan’ bread, but this does not mean that we have to be disparaging about bread that has been produced efficiently. Standards of living and nutritional advances have seen the average height in the UK increase by three quarters of an inch each generation and the average life expectancy of a 65-year-old increase by four to five years over the past century. So long as hunger and starvation still afflict much of the world’s population, producing cheap, quality food must remain a priority.? Peter Martin is a lecturer at the University of Manchester’s School of Chemical Engineering and Analytical Science
prescriptions are made for conditions which in individual circumstances may be better helped by other forms of care there is potential overlap in patients being prescribed multiple drugs to manage the same condition individuals are remaining on repeat prescriptions which roll over – often for many years – without being reviewed Doctors, pharmacists and patients need to work together to ensure people are on the right medicines, for the right amount of time. NHS England’s recent successes in reducing unnecessary antibiotics and medicines with care homes and GP practices, on polypharmacy, and on beginning to end overmedication for people with learning disabilities, all show what can be – and indeed now is being – done on this important topic. Estimated total NHS spending on medicines in England has grown from £13 billion in 2010 to 2011 to £18.2 billion in 2017 to 2018. This is an average growth of around 5% a year – with 1.1 billion prescription items dispensed in primary care by GPs and pharmacists.Health Survey England 2016 found that nearly half of over 75-year-olds surveyed were taking 5 or more medicines, with this percentage rising the older people get.While in the majority of cases patients will be receiving multiple drugs due to specific or complex needs, the review will look at how to ensure treatment remains up to date and appropriate so patients feel as well as possible.The review will look at how doctors and pharmacists can be supported to review prescriptions and ensure patients are receiving the most appropriate treatment for their needs. It will also look at instances where: addressing ‘problematic polypharmacy’ – where a patient is taking multiple medicines unnecessarily creating a more efficient handover between primary and secondary care, for example ensuring GPs have the data they need and feel able to challenge and change prescribing made in hospitals improving management of non-reviewed repeat prescriptions – including encouraging patients to ask questions about their treatment to ensure they don’t remain stuck on repeat prescriptions which are no longer needed the role of digital technologies in reducing overprescribing the increased role for other forms of care, including social prescribing the Medicines Safety Programme, which is co-ordinating work on reducing medication errors NHS England’s Medicines Value Programme, which is working to reduce variation in prescribing using clinical evidence and the creation of metrics Keith Ridge, Chief Pharmaceutical Officer at NHS England, said: Recent advances in medicine have led to fantastic developments in managing and treating certain conditions, but poorly managed prescribing can lead to serious issues for patients such as increased admissions to hospital or antibiotic resistance. As we invest an extra £20.5 billion a year into our NHS we want to empower doctors and pharmacists to use the data available to ensure patients get the medicines they need and stop taking those that no longer benefit them. We also need to back our GPs to move towards alternatives such as social prescribing, so we can offer more tailored healthcare that focuses on prevention to stop people from becoming ill in the first place – improving care and reducing the burden on the NHS. The review will be led by Chief Pharmaceutical Officer Dr Keith Ridge. It will look at: Health and Social Care Secretary Matt Hancock said: The review will take into consideration individual circumstances where patients may be most at risk of adverse effects from overprescribing. Overprescribing can be particularly dangerous for older people, who are often taking several different medicines to manage complex conditions and may suffer side effects that lead to them falling and being admitted to hospital.It will consider how new digital systems can assist primary care providers in creating a better picture of overprescribing in their area to allow more targeted action, ultimately creating better personalised care for patients.Addressing overprescribing will be an important part of the Department of Health and Social Care’s prevention strategy.Action is already being taken across the health system to address over-prescribing, including:
Details have been revealed of a new funding scheme to help bakers across Scotland buy or modernise equipment.Applications to the £125,000 Scottish Bakers Grant Scheme, which was announced in June, can now be made by small family-run or independent businesses.The scheme has been developed to support and encourage the growth of independent Scottish bakers and their ability to innovate and respond to changing customer demands by:Improving the quality of retail environmentsProviding a better/more diverse food-to-go offering for consumers (with an emphasis on healthier options)Improving operational efficiency and flexibilityReducing environmental impact of operationsA maximum grant of £5,000 is available per business, and applicants must provide at least 25% of the total project costs.Funds will be paid to successful applicants on completion of all works and will be subject to evidence the work has been completed and relevant invoices issued. Businesses must also show that they are compliant with legislation covering food hygiene and health and safety.”This fund will provide vital funding to support bakers allowing them to invest in their businesses for the future helping them to meet the needs of the changing modern high-street,” said Scottish Bakers chief executive Alasdair Smith.”Scottish bakers are skilled crafts people baking fresh goods daily and many of our members are stalwarts of our high streets and communities. And of course a strong bakery sector is also good for Scotland Plc supporting 12,000 jobs securing the future of our much loved daily bread, savoury snacks and sweet treats.”The scheme follows the launch of a capital investment programme, managed by the Scottish Grocers Federation, in 2017 to help small independent grocers introduce food-to-go stations in their stores.To apply for funding to the Scottish Bakers Grant Scheme, bakers will need to complete an application form and budget form on the Scottish Bakers website. The deadline for applications received is 27 September 2019.
For the third consecutive night, belovedly brown band Ween set up shop at the Brooklyn Bowl in Las Vegas, NV for the finale of their run. Though there was no shortage of hits from Ween throughout the night, the set was marked by a unique event: a marriage proposal.About halfway through the set, the members of Ween called upon the happy couple and let the magic of romance in Vegas fill the air. The two diehard Ween fans had a bit of a mishap when they couldn’t find the engagement ring, but quickly sorted it out and celebrated the big occasion. It was a triumphant moment of Ween fandom for all to enjoy.On top of that, this Sunday show was one of the band’s best yet, with incredible versions of songs like “Fluffy,” “Polka Dot Tail,” “Voodoo Lady” and many more. You can check out a couple videos from the night, of “Albino Sunshine Girl” and “Put the Coke on my Dick,” courtesy of Fatah Ruark’s Live Music Archive. A few more videos can be seen below, courtesy of ikwil70. Check out the full setlist below, as well as a photo gallery from Erik Kabik.Setlist: Ween | Brooklyn Bowl | Las Vegas, NV | 2/19/17Set: She Wanted to Leave, Buckingham Green, Spinal Meningitis, Beacon Light, Learnin to Love, Albino Sunburned Girl, Voodoo Lady, Big Jilm, Ooh Vah Lah, Stroker Ace, Put the Coke on my Dick, The Grobe, Licking the Palm for the Guava>> Mushroom Festival in Hell, Laura, Bare Hands, Marriage Mishap>>Deaner>>Iron Man intro, Fancy Pants, Touch My Tooter, It’s Gonna be a Long Night, Ace of Spades, Fluffy, Polka Dot TailEncore: Poopship Destroyer Load remaining images
Leon Bridges will embark on a 29-show tour that will bring him through much of the United States and parts of Canada. The young singer, whose sound draws heavily from early ‘60s soul and R&B, will be supported by special guests Jon Batiste & Stay Human, Khruangbin, and Masego.Ahead of his big outing, Bridges will treat his fans to a hometown show on June 9th in Irving, TX, just outside his native Forth Worth. Two months later, he’ll headline the picturesque Red Rocks Amphitheatre in Morrison, CO on August 9th before hitting the road the next two months. The run will include two-night stands in Austin, TX and New York City.Bridges’ forthcoming tour will be in support of his sophomore album, Good Thing, which is slated for release on May 4th via Columbia Records. The singer has already put out two tracks from the new record—“Bet Ain’t Worth The Hand” and “Bad Bad News”.Pre-sale tickets for Bridge’s tour are now on sale via his website.Leon Bridges – “Bet Ain’t Worth The Hand” Leon Bridges Tour Dates:June 9 – Irving, TX @The Pavilion at Irving Music Factory *August 9 – Morrison, CO @ Red Rocks Ampitheater ^%August 27 – Raleigh, NC @ Red Hat Amphitheater %August 28 – Atlanta, GA @ Chastain Park %August 29 – Nashville, TN @ Ascend Amphitheater %August 31 – New Braunfels, TX – Whitewater Amphitheater %September 1 – Austin, TX @ ACL Live at the Moody Theater %September 2 – Austin, TX @ ACL Live at the Moody Theater %September 4 – Phoenix, AZ @ Comerica Theatre %September 5 – San Diego, CA @ Open Air Theatre %September 7 – Berkeley, CA @ Greek Theatre %September 8 – Las Vegas, NV @ Pearl Concert Theater %September 11 – Los Angeles, CA @ Greek Theatre ^September 12 – Santa Barbara, CA @ Santa Barbara Bowl ^September 14 – Seattle, WA @ WaMu ^September 15 – Troutdale, OR @ Edgefield ^September 16 – Vancouver, BC @ PNe Ampitheater ^September 18 – Missoula, MT @ Big Sky Brewing Company ^September 20 – Saint Paul, MN @ Palace Theatre ^September 23 – Milwaukee, WI @ BMO Harris Pavilion ^September 24 – Chicago, IL @ Aragon Ballroom ^September 25 – Detroit, MI @ Fox Theatre ^September 27 – Toronto, ON @ TD Echo Beach ^September 28 – Montreal, QC @ Place des Arts – Wilfrid Pelletier Hall ^September 30 – Philadelphia, PA @ The Fillmore ^October 3 – Washington, DC @ Anthem ^October 4 – Boston, MA @ Agganis Arena ^October 5 – New York, NY @ Radio City Music Hall ^October 6 – New York, NY @ Radio City Music Hall ^*with Jon Batiste & Stay Human% with Masego^ with KhruangbinView All Tour Dates
The National Institutes of Health (NIH) today announced that it is resuming funding embryonic stem cell research.“We are pleased with the…interim ruling” yesterday by a three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit, ” which will allow promising stem cell research to continue while we present further arguments to the Court in the weeks to come,” the announcement states. It continues:“With the temporary stay in place, NIH has resumed intramural research and will continueits consideration of grants that were frozen by the preliminary injunction on August 23. The suspension of all grants, contracts, and applications that involve the use of human embryonic stem cells has been temporarily lifted. Human embryonic stem cell research holds the potential for generating profound new insights into disease, cell-based therapeutics, and novel methods of screening for new drugs.”Yesterday’s appellate court ruling has at least temporarily lifted a lower court ban on federal funding of human embryonic stem cell research.However, the court warned that “the purpose of this administrative stay is to give the court sufficient opportunity to consider the merits of the emergency motion for stay and should not be construed in any way as a ruling on the merits of that motion.”Told of yesterday’s court order, Doug Melton, co-director of Harvard’s programs in stem cell science, said “this is terrific news. I realize that this is a temporary order, but I am hopeful that the Court of Appeals understands the enormous potential this research holds, it’s promise for millions of patients, and will allow regular funding of the work to resume.”The three judges on the appellate panel are all appointees of either President George H. W. Bush or President George W. Bush.The U.S. Department of Justice is asking the court to lift an injunction issued by Royce C. Lamberth, Chief Judge of the U. S. District Court for the District of Columbia, barring all federal funding of human embryonic stem cell research.Supporters of stem cell research, including Harvard President Drew Faust, have said that barring the research will delay the search for cures for a host of illness effecting millions of persons around the globe.In a statement issued Tuesday, Faust said that “this vital work is now in jeopardy…We hope that the temporary injunction will soon be lifted and that Congress will take the steps necessary to ensure that stem cell scientists can carry on their work vigorously and responsibly, in the interests of the millions of people who may someday enjoy itsbenefits.”Harvard has joined the Coalition for the Advancement of Medical Research (CAMR) – a coalition of research universities and patient advocacy groups – in filing an amicus brief in support of the Justice Department’s appeal of the injunction.The Associated Press quoted Lisa Hughes, president CAMR, as saying that ”it is crucial that federal funding for human embryonic stem cell research be restored permanently and this stay is a step in that direction,” Hughes said in a statement. ”While this issue continues to be argued in the courts, we call on Congress to move swiftly to resolve this issue and secure the future of this important biomedical research.”
LONDON (AP) — Britain is expanding a coronavirus vaccination program that has seen more than 6 million people get the first of two doses — even as the country’s death toll in the pandemic approaches 100,000. Health Secretary Matt Hancock said Sunday that three-quarters of the U.K.’s over-80s have received a vaccine shot. He said three-quarters of nursing home residents have also had their first jab. More than 6.3 million doses of vaccine had been administered by Sunday. Health officials aim to give first shots to 15 million people, including everyone over 70, by Feb. 15. Britain’s vaccination campaign is a rare success in a country with Europe’s worst confirmed coronavirus outbreak. The U.K. has recorded 97,939 virus deaths, the fifth highest in the world.
Both Rosie O’Donnell and Boy George reunited with the cast of their Broadway-flop-we-love Taboo at 54 Below this weekend, but, like divorced parents splitting up time with their kids, they never actually appeared together. Instead, the duo arrived separately for the electrifying four-performance run, Taboo producer O’Donnell taking in the first show on February 7 and a goateed George, whose life and music give the show its beat and heart, popping in on February 8. The two mega-talents famously clashed during the difficult birth of the musical, but O’Donnell has recently spoken well of the pop icon, who reportedly cleaned up a nasty drug habit that made him a miserable collaborator at the time. Happily, Broadway.com photographer Bruce Glikas was on hand to capture both family portraits. Check back on Monday for more photo coverage of Taboo: 10 Years Later. View Comments
Due to the oversupply of corn over the past few years, farmersgot low prices for their crops. But corn prices have the potentialto strengthen this year, Lee said.More corn was sold than produced in the United States last year.This reduced the oversupply stock and strengthened prices. Leesaid the trend should continue this year.Farmers had above-average production last year and still soldmore corn than they could grow. If this year is just an averageyear, the U.S. should again sell more corn than is grown. Thiswould further reduce the oversupply stock and strengthen prices.Better Prices at Higher Cost “The growers are facing a little better price environmentthis year,” Lee said. “But they’re having to spend alittle bit more money on growing the crop.”Nitrogen is the main fertilizer used in producing Georgia’s $84million corn crop. The price of natural gas, which is used tomanufacture nitrogen, has increased. So nitrogen prices have risen,too, by as much as 12 cents per pound.The nitrogen price increase will add as much as $30 per acre tosome farmers’ costs, Lee said. Though corn prices look betterthan last year, farmers still face a narrow profit margin on thecrop.Nothing Without Water To grow corn, you’ve got to have water. “Whether it comesfrom the sky or irrigation,” Lee said, “you’ve got tohave it.”The impending drought will cause problems for corn farmers. Droughtconditions have hit southwest and east Georgia severely. In thesetwo regions, a farmer has little chance of producing profitableyields without irrigation. In many cases last year, farmers abandonedentire fields of dryland corn, Lee said.Most irrigation systems use diesel fuel, he said. The increasein diesel fuel cost will add additional overhead to corn farmers.Planting About the Same Heavy rains fell over most of the state the first week of March.Some areas received as much as 3 to 4 inches. This timely rainfell as most corn farmers where planting their crop.Farmers who grow corn like to go ahead and get the corn crop inthe ground and fertilized before it’s time to plant cotton andpeanuts, Lee said. Sometimes they plant a little too early. Cornthat was planted in late-February runs the risk of freeze damage.Low temperatures in Georgia hovered around freezing in the firstweek of March. Any damage to the emerging corn crop is yet tobe determined, Lee said.Despite the encouraging rains and prices, Lee said corn farmersthis year will plant about the same amount of land as last year,about 350,000 acres. Georgia farmers face another year of severe drought, and the pricesof many major commodities remain low. But the long rows aheadlook a little better for corn growers, says a University of Georgiaexpert.Recent rains have corn farmers “full throttle” puttingone of this year’s first row-crops into the ground, said DeweyLee, an Extension Service agronomist with UGA College of Agriculturaland Environmental Sciences.Better Prices